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Massive Liver Cell Necrosis Induced in the Pig
with Carbon Tetrachloride
J. W. VAN LEENHOFF, ROSEMARY HICKMAN, S. J. SAUNDERS, J. TERBLANCHE
SUMMARY
An attempt was made to induce massive liver necrosis
in the pig by the injection of varying doses of carbon tetra-
chloride into the afferent vessels of the liver. The optimal
route and dose of injection were assessed as well liS the
effect of prior phenobarbitone administration. Survival,
and biochemical and histological changes were noted.
A preliminary trial of exchange transfusion showed that
the model could be used, but a number of variables
complicates evaluation in this biological system. A large
number of animals would be needed under strictly paired
conditions in order to draw significant conclusions.
S. Afr. Med. l., 48, 1201 (1974).
Massive liver necrosis remains an important complication
of infectious or drug-induced hepatitis and has a mor-
tality rate of 80 - 90%.' This relates partly to inadequate
methods of treatment resulting from inability to perform
adequate clinical trials. An animal model of acute liver
failure is urgently needed for the controlled assessment
of procedures such as exchange transfusion, cross-circula-
tion and hepatic assist with the isolated perfused liver.
For the purposes of this study, the following ideal model
was defined, with the requirements of: (i) reversibility-
such that the animals might respond and recover with
treatment; (ii) reproducibility-with near uniform morta-
lity, since evidence of the effectiveness of treatment would
rest almost exclusively upon survival and reversal of
biochemical changes; and (iii) death from liver failure with
preceding disturbance in the level of consciousness
commencing 6 - 12 hours after injection, with death of
the animal within 36 - 48 hours.
Some previous attempts to cause massive liver necrosis
in animals have included surgical manoeuvres which are
generally irreversible,'·' with the exception of partial
devascularisation: Others have used drug administration.
Galactosamine injected intraperitoneally into the rat causes
a histological picture similar to that of massive necrosis
in humans,'" but use in large animals would be prohibi-
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tively expensive. Dimethylnitrosamine,' while successful,
requires strict laboratory control because of the hazards
of carcinogenesis. Carbon tetrachloride has been used
with some success in the rat;,1. and more recently in the
monkey." Injection into a mesenteric radicle of the portal
vein induced acute liver necrosis with coma within 6
hours.
This study investigated the pig as a readily available
laboratory animal, and attempts were made to determine
the optimal dose of carbon tetrachloride to be used,
the optimal route of injection, and the value of adminis-
tration of phenobarbitone to enhance the hepatotoxic effect
of carbon tetrachloride."
MATERIALS AND METHODS
Pigs of Landrace X Large White stock of either se,x and
weighing between 12 and 30 kg were used. Their ages
ranged from 25 to 60 days and they were fed commercial
'Creep' mea)" until pre-operative starvation. For injection
of carbon tetrachloride, light anaesthesia was induced
with halothane, nitrous oxide and oxygen given via an
endotracheal tube with intermittent positive pressure
ventilation. Carbon tetrachloride was injected directly into
a branch of the hepatic artery or into a catheter inserted
via the splenic vein to lie at the confluence of the splenic
and superior mesenteric veins.
Phenobarbitone powder was given daily for 5 days to
one group of pigs. As no previous dose schedule could
be found for the pig, an arbitrary amount of 1 g/litre
was dissolved in the 5 litres of available drinking water.
No measurement of induction by assay of cytochrome
P450 or electron microscopy was made (see Discussion).
Biochemical tests of liver damage were chosen to
align with clinical practice and sera were analysed for
aspartate transaminase, bilirubin and alkaline phos-
phatase. Histological sections of the liver, kidneys and
lungs were taken at death or sacrifice in all animals.
The experimental groups were:
Injection of carbon tetrachloride 0.05 ml/kg into
the hepatic artery-IO pigs.
TI (a) Injection of carbon tetrachloride 0,05 ml/kg into
the portal vein-2 pigs.
(b) Injection of carbon tetrachloride 0,14 ml/kg into
the portal vein-25 pigs.
III Injection of increasing doses of' carbon tetra-
chloride into the hepatic artery following admini-
stratio:1 of phenobarbitone-39 pigs.
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RESULTS Dose Response
Route of Injection
Injection of carbon tetrachJo~ide 0,05 ml/kg into the
hepatic artery of 10 pigs re_uited in diffuse liver damage.
and a mean survival of 10, I ± I days. Injection of this
volume into the portal vein in 2 animals resulted in
protracted survival probably related to the localised
damage which occurred as a result of ,treaming in the
portal circulation. At a higher dose (0.14 ml/kg) in 25
anima:s. mean survival was 15 ± 2 hours (range 2 - 52
hours), with 2 animals sacrificed at 7 days.
In 39 animals in group Ill, increasing doses of carbon
tetrachloride were given into the hepatic artery after
phenobarbitone administration. No specific dose response
was noted from the survival data. although animals given
Fig. 1. The tempo of enzyme increases resulting from
injection of 0,05 ml/kg carbon tetrachloride into the
hepatic artery, with or without prior phenobarbirone
administration.
smaller doses were more likely to survive 7 days (Table I).
A wide range of aspartate transaminase levels was found,
and no dose response was noted. Alkaline phosphatase




























TABLE I. EXPERIMENTAL DESIGN SHOWING THE SCHEDULE
AND ROUTE OF INJECTION, THE NUMBER OF ANIMALS,
THE DOSE OF CARBON TETRACHLORIDE AND THE MEAN
SURVIVAL TIME WITH THE STANDARD ERROR OF THE
MEAN
Since hepatic arterial injection resulted in more diffuse
damage, this route was chosen to assess the effect of
administration of phenobarbitone. Comparison of the
results of survival in groups I and llI(d) shows that the
Group No. CCI4 dose ml/kg Survival
I 10 0,05 10 -+- 1 days
11 (a) 2 0,05 Sacrificed 3
months
(b) 25 0,14 15±2 hours*
2 sacrificed.
III (a) 4 0,0125 32 ± 2 hours*
2 sacrificed
(b) 9 0,025 36±11 hours*
2 sacrificed
(c) 4 0,035 - 0,045 37 ± 17 hours
(d) 16 0,05 25 -+- 3 hours
(e) 6 0,1 40 -+- 10 hours
Effect of Administration of Phenobarbitone
Where not o~herwise indicated in the table. animals were sacrificed
at 7 days.
Group I - injection of carbon tetrachloride into the hepatic artery;
11 - injection of carbon tetrachloride into the portal vein;
III - injection of carbon tetrachloride into the hepatic artery
after administration of phenobarbitone.
'" Calculations of the mean survival time have been made excluding
da:a from the sacrificed animals.
administration of phenobarbitone reduced mean survival
time from days to hours (Table I). The pattern of elevation
of aspartate transaminase and alkaline phosphatase, shown
in Fig. I, was apparent earlier after administration of
phenobarbitone but no greater rise was observed. Bilirubin
levels were not elevated above 2 mg/100 ml in any
animal.
d
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Fig. 3. The changes in liver histology resulting from
injection of carbon terracbloride-{Ieft) low dose with
relatively minor effects; (right) more severe damage caused
by the larger dose (H. and E. x 40).
into the hepatic artery (P<O,OOI). Thus there was. bio-
chemical"" but not clinical evidence of coma, and one
aspect of the ideal model was not met.
Preliminary Trial
hours
Fig. 2. The enzyme changes resulting from increasing
doses of carbon terracbloride injected into the hepatic
artery following phenobarbitone administration.
Histology
Histological evidence of liver damage (Fig. 3) was more
apparent with increasing doses. Initial centrilobular
damage (shown on left in Fig. 3) gradually extended to
involve the whole lobule (Fig. 3, right) as the dose was
increased from 0,025 ml/kg to 0,1 ml/kg.
Complications
Hypoglycaemia was a marked feature requiring moni-
toring of blood sugar every two hours and continuous
administration of intravenous dextrose. Large doses of
carbon tetrachloride given into the hepatic artery without
prior phenobarbitone. administration caused death from
pulmonary oedema and convulsions before hepatic
necrosis was evident.
Coma developed suddenly preterminally in the pig and
there was little evidence of deterioration until just before
death. In 12 animals, which were given phenobarbitone,
cerebrospinal fluid glutamine levels rose significantly, from
a normal mean of 18,0 mg/100 ml to 94,2 mg/100 ml
8 hours after injection of 0,05 ml/kg carbon tetrachloride
In a preliminary trial of the use of exchange transfusion,
25 control animals were given 0,14 ml/kg carbon tetra-
chloride into the portal vein, with a mean survival of
15 ± 2 hours, excluding 2 animals which survived 7
days. In 9 animals given the same dose of carbon
tetrachloride, exchange transfusion of 2 litres of fresh
heparinised pig blood was performed at 6 hours. Five
animals survived a mean of 13 ± 2 hours, and 4 were
sacrificed after 7 days.
DISCUSSION
This study aimed to establish a reproducible, reversible
model of acute liver failure in the pig, with coma and
death resulting within 36 - 48 hours of administration of
carbon tetrachloride. This time interval was to be used
to define the biochemical status of the animals, to note
changes in level of consciousness and to initiate treatment
on a controlled basis.
An unsuccessful attempt was made to define a dose-
related response to injection of carbon tetrachloride.
Administration of 0,05 ml/kg via the hepatic artery or the
portal vein resulted in long survival. Increase of the
portal venous dose to 0,14 mt/kg caused death in 40% of
the 25 animals within the desired time, but survival ranged
from 2 to 52 hours. Administration of phenobarbitone
before injection of carbon tetrachloride into the hepatic
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dependent upon the dose-volumes from 0,035 to 0, I
ml/kg resulted in similar survival times. Phenob<:rbitone
was given in an attempt to render the carbon tetrachloride
more specifically hepatotoxic." Since no data were avail-
able for administration to the pig, the choice of do~e
and route was arbitrary. Oral administration was probably
unreliable, but in a recent study in this laboratory, Miller
and Saunders" found that phenobarbitone given by intra-
muscular injection for S days was also followed by variable
response to paracetamol administration, despite fivefold
elevation of cytochrome P4S0 (unpublished observations).
Phenobarbitone reduced survival time in animals treated
with carbon tetrachloride from days to hours, but did not
result in any obvious dose-related response. It has sub-
sequently been suggested that the drug should be given for
10 days to achieve_ optimum levels of cytochrome P4S0
(Davis; personal communication).
In a preliminary trial of the value of exchange trans-
fusion in this model, 44% of treated animals survived for
7 days, while only 8% of untreated animals were long
survivors. There is a significant correlation between
survival and treatment (P<O,OS using chi-squared analysis),
but long survivors among untreated animals made this
conclusion unsatisfactory.
It is concluded that this model may be of use with
some modification to the original ideal design. Although
the mean survival time was suitable, a wide range should
be anticipated, and 25% of animals in this series died
before 8 hours, i.e. when treatment would have been
instituted. Coma was not as obvious as is described in
the monkey," but evidence for liver necrosis was drawn
from elevation of aspartate transaminase and alkaline
phosphatase, and histological features were similar to
those reported in rats' and sheep.'" Total massive necrosis
as seen in rats given halothane" or fluoroxenelS after
phenobarbitone induction, was not seen.
The preliminary trial of treatment by exchange trans-
fusion showed this to be a feasible procedure in the pig
but emphasised the need to use large numbers of animals
under strictly paired conditions to enable meaningful
conclusions to be drawn.
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